STATCenter·
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
Read at STAT →
Health · 1 sources covering this
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/6c00d0d510f849de39322613586fdc1cf8aaf6f0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides"></iframe>
